Skip to main content
Tech.euFundingExplorerBeta

NeraCare GmbH

NeraCare develops and commercializes molecular diagnostic tests for patients with skin cancer.

Frankfurt, GermanyFounded 2015www.melagenix.info
Total raised
€0
€0
Funding rounds
1
Investors
2
distinct backers
Active since
2020-05
latest 2020-05

Funding by year

EUR raised per year

Signals

Medium confidence
Raise-next likelihood11
base rate 30% for Other
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds

Related news

Similar companies

same sector or country